TCP Reliable, ATP Sign Pact

TCP Reliable and Alternatives Technology Pharma (ATP) have signed multi-year commercial agreements for the temperature controlled packaging and cold chain market in North America. Under this agreement, TCP will be the exclusive reseller and distributor of ATP’s cold chain services and monitoring solutions for the U.S. market. TCP acquires the rights for commercializing ATP’s computerized solutions: ATP-ThermoProfile, ATP-Sentinel, ATP-Mirador and ATP-DOCOS, all solutions being specially developed for the pharmaceutical and life sciences industry and fulfilling the regulations of the U.S., Canada and Europe.

Also, ATP will be the exclusive sales agent of TCP’s temperature controlled packaging solutions in Canada. The two companies also agree to install in Laval, Quebec, a joint-ventured laboratory for all design and testing activities related to temperature controlled and cold chain packaging in Canada. The pharmaceutical and life sciences market in North America, including pharmaceutical developers, importers, manufacturers, wholesalers, transporters and retailers, will be the primary target of ATP and TCP companies.

Maurice Barakat, president and chief executive officer of TCP Reliable said, “Our pharmaceutical customers will have easy access to the tools required to help them control their supply chain processes and to implement temperature controlled packaging solutions best suited to their needs.”

Jean Bedard, vice president and chief executive officer of ATP said, “With TCP as a strategic partner, we are proud to propose to the North American Life Sciences industry a complete and integrated cold chain package going from the cold chain compliance services through environmental conditions monitoring solutions, to the cold chain packaging and supplies. Together, ATP and TCP will provide a more complete cold chain expertise to fulfill the needs of the North American Life Sciences industry.”